The clinical effectiveness and costeffectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: Systematic reviews, registry database analyses and economic evaluation

C. Robertson, S.K. Arcot Ragupathy, C. Boachie, J.M. Dixon, C. Fraser, R. Hernández, S. Heys, W. Jack, G. Kerr, G. Lawrence, G. MacLennan, A. Maxwell, J. McGregor, G. Mowatt, S. Pinder, L. Ternent, R. Thomas, L. Vale, R. Wilson, S. ZhuF. Gilbert

Research output: Contribution to journalArticlepeer-review


Review finds that surveillance following treatment of primary breast cancer is likely to improve patient survival, with a strategy of mammography alone every 12–24 months appearing to have the highest net benefits. To optimise the use of resources and achieve maximum patient benefit, women at a higher risk of developing ipsilateral breast tumour recurrence or metachronous contralateral breast cancer should be offered more comprehensive and more frequent surveillance
Original languageUndefined
Pages (from-to)34
JournalHealth Technol Assess
Publication statusPublished - Sept 2011

Cite this